Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications.
Cardiovascular magnetic resonance
Left ventricular filling pressure
Right heart catheterization
Journal
European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263
Informations de publication
Date de publication:
07 07 2022
07 07 2022
Historique:
received:
10
05
2021
revised:
13
03
2022
accepted:
07
04
2022
pubmed:
6
5
2022
medline:
9
7
2022
entrez:
5
5
2022
Statut:
ppublish
Résumé
Non-invasive imaging is routinely used to estimate left ventricular (LV) filling pressure (LVFP) in heart failure (HF). Cardiovascular magnetic resonance (CMR) is emerging as an important imaging tool for sub-phenotyping HF. However, currently, LVFP cannot be estimated from CMR. This study sought to investigate (i) if CMR can estimate LVFP in patients with suspected HF and (ii) if CMR-modelled LVFP has prognostic power. Suspected HF patients underwent right heart catheterization (RHC), CMR and transthoracic echocardiography (TTE) (validation cohort only) within 24 h of each other. Right heart catheterization measured pulmonary capillary wedge pressure (PCWP) was used as a reference for LVFP. At follow-up, death was considered as the primary endpoint. We enrolled 835 patients (mean age: 65 ± 13 years, 40% male). In the derivation cohort (n = 708, 85%), two CMR metrics were associated with RHC PCWP:LV mass and left atrial volume. When applied to the validation cohort (n = 127, 15%), the correlation coefficient between RHC PCWP and CMR-modelled PCWP was 0.55 (95% confidence interval: 0.41-0.66, P < 0.0001). Cardiovascular magnetic resonance-modelled PCWP was superior to TTE in classifying patients as normal or raised filling pressures (76 vs. 25%). Cardiovascular magnetic resonance-modelled PCWP was associated with an increased risk of death (hazard ratio: 1.77, P < 0.001). At Kaplan-Meier analysis, CMR-modelled PCWP was comparable to RHC PCWP (≥15 mmHg) to predict survival at 7-year follow-up (35 vs. 37%, χ2 = 0.41, P = 0.52). A physiological CMR model can estimate LVFP in patients with suspected HF. In addition, CMR-modelled LVFP has a prognostic role.
Identifiants
pubmed: 35512290
pii: 6576529
doi: 10.1093/eurheartj/ehac207
pmc: PMC9259376
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2511-2522Subventions
Organisme : Wellcome Trust
ID : 220703/Z/20/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008894/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 215799/Z/19/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/14/6/31350
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR-RP-R3-12-027
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
ESC Heart Fail. 2021 Feb;8(1):566-576
pubmed: 33230957
Circ Res. 1962 Aug;11:315-8
pubmed: 14467155
Arq Bras Cardiol. 2017;108(6):552-563
pubmed: 28562831
Ann Intern Med. 1991 Mar 1;114(5):345-52
pubmed: 1825164
Eur Heart J Cardiovasc Imaging. 2017 Sep 01;18(9):961-968
pubmed: 28444160
J Cardiovasc Magn Reson. 2018 Aug 30;20(1):61
pubmed: 30165869
Br J Anaesth. 1988;60(8 Suppl 1):85S-89S
pubmed: 3284571
Echo Res Pract. 2020 Dec;7(4):G59-G93
pubmed: 33112828
Circulation. 1976 Oct;54(4):662-71
pubmed: 786501
Int J Cardiol. 2021 Aug 1;336:105-112
pubmed: 34044022
J Am Heart Assoc. 2021 Sep 21;10(18):e021165
pubmed: 34476984
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Heart. 2021 May;107(9):697-704
pubmed: 33402364
Circulation. 2006 Aug 15;114(7):654-61
pubmed: 16894035
J Am Coll Cardiol. 2016 Apr 19;67(15):1815-1825
pubmed: 27081022
Circ Heart Fail. 2014 Nov;7(6):935-44
pubmed: 25286913
Am J Cardiol. 2008 Nov 1;102(9):1131-5
pubmed: 18940278
Magn Reson Imaging. 2021 Feb;76:116-122
pubmed: 33221422
Sci Rep. 2020 Jun 18;10(1):9908
pubmed: 32555252
JACC Cardiovasc Imaging. 2010 Apr;3(4):409-20
pubmed: 20394903
J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89
pubmed: 27899132
Eur J Echocardiogr. 2004 Aug;5(4):262-71
pubmed: 15219541
Eur Respir Rev. 2015 Dec;24(138):642-52
pubmed: 26621978
JACC Heart Fail. 2017 Nov;5(11):795-801
pubmed: 29032138
J Cardiovasc Magn Reson. 2019 Oct 7;21(1):61
pubmed: 31590664
Heart. 2002 Apr;87(4):336-9
pubmed: 11907005
Circulation. 2017 Feb 28;135(9):825-838
pubmed: 28039229
Sci Rep. 2018 Sep 26;8(1):14436
pubmed: 30258186
J Thorac Cardiovasc Surg. 2010 Oct;140(4):807-15
pubmed: 20117802
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17
pubmed: 32089132
J Cardiovasc Magn Reson. 2018 Jan 11;20(1):4
pubmed: 29321034
Eur Heart J. 2014 Nov 21;35(44):3103-12
pubmed: 25161181
Int J Cardiovasc Imaging. 2021 Oct;37(10):3019-3025
pubmed: 33978936
J Am Soc Echocardiogr. 2018 Jan;31(1):79-88
pubmed: 29111121
J Am Coll Cardiol. 2017 Apr 18;69(15):1937-1948
pubmed: 28408024
JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047
pubmed: 23769494
Heart Rhythm. 2011 Aug;8(8):1177-82
pubmed: 21376836
Eur Heart J Cardiovasc Imaging. 2022 Jan 24;23(2):e34-e61
pubmed: 34729586
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
J Cardiovasc Dev Dis. 2020 Sep 10;7(3):
pubmed: 32927744
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
J Am Coll Cardiol. 2014 Mar 25;63(11):1112-8
pubmed: 24518490
Sci Rep. 2021 Jan 12;11(1):617
pubmed: 33436786
Circulation. 2020 Jan 14;141(2):115-123
pubmed: 31865771